ULTRALIFE CORP (ULBI) Stock Analyst Ratings
USA - NASDAQ:ULBI - US9038991025 - Common Stock
6.95 USD
-0.08 (-1.14%)
ChartMill assigns a Buy % Consensus number of 83% to ULBI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.28. This target is 105.47% above the current price.
ULBI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ULBI.
In the previous month the buy percentage consensus was at a similar level.
ULBI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-15 | Benchmark | Reiterate | Buy -> Buy |
| 2024-06-27 | Benchmark | Maintains | Buy -> Buy |
| 2024-03-05 | Benchmark | Maintains | Buy -> Buy |
| 2023-08-08 | Benchmark | Reiterate | Buy -> Buy |
| 2021-03-26 | Benchmark | Initiate | Buy |
ULTRALIFE CORP / ULBI FAQ
What is the price target for ULBI stock?
7 analysts have analysed ULBI and the average price target is 14.28 USD. This implies a price increase of 105.47% is expected in the next year compared to the current price of 6.95.
How do analysts rate ULTRALIFE CORP (ULBI)?
The consensus rating for ULTRALIFE CORP (ULBI) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed ULTRALIFE CORP (ULBI)?
The number of analysts covering ULTRALIFE CORP (ULBI) is 7.